<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="48562">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01872728</url>
  </required_header>
  <id_info>
    <org_study_id>2012.774</org_study_id>
    <secondary_id>2012-005831-97</secondary_id>
    <nct_id>NCT01872728</nct_id>
  </id_info>
  <brief_title>Facial Block for Outpatient Rhinoplasty Analgesia</brief_title>
  <acronym>FABLORA</acronym>
  <official_title>Efficacy of Facial Block for Outpatient Rhinoplasty Analgesia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospices Civils de Lyon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospices Civils de Lyon</source>
  <oversight_info>
    <authority>France: Agence Nationale de Sécurité du Médicament et des produits de santé</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A bilateral facial block (infraorbital and infratrochlear) will be performed immediately
      after intubation in patients undergoing outpatient rhinoplasty with 2.5% levobupivacaine
      (intervention group) or saline as control. Intravenous saline or morphine will be
      administered at the end of surgery in intervention or control groups, respectively. In case
      of pain in post-anesthesia care unit (numerical pain score &gt;3 on a 0-10 scale), both groups
      will receive intravenous morphine titration. The total perioperative morphine consumption
      (intraoperative and in post-anesthesia care unit) will be compared between groups. Pain
      intensity, presence of nausea/vomiting and patient's satisfaction will be compared between
      groups.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>June 2013</start_date>
  <completion_date type="Anticipated">December 2014</completion_date>
  <primary_completion_date type="Actual">December 2013</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Total morphine consumption during the perioperative period (operating theater and post-anesthesia care  unit)</measure>
    <time_frame>J0</time_frame>
    <safety_issue>No</safety_issue>
    <description>At the end of post-anesthesia care unit stay</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain intensity in post-anesthesia care unit</measure>
    <time_frame>J0 (At arrival in post-operative care unit)</time_frame>
    <safety_issue>No</safety_issue>
    <description>0-10 numerical rating scale (NRS) : from 0 = no pain to 10 = worst pain imaginable</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative nausea and vomiting</measure>
    <time_frame>J1 (At day 1 after surgery)</time_frame>
    <safety_issue>No</safety_issue>
    <description>Presence or absence of nausea/vomiting</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient satisfaction at day 1</measure>
    <time_frame>J1 (At day 1 after surgery)</time_frame>
    <safety_issue>No</safety_issue>
    <description>0-3 scale (0 = bad, 1 = poor, 2 = good, 3 = excellent)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Outpatient Rhinoplasty</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>placebo for the realization of the facial block and morphine for intraoperative analgesia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Levobupivacaine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Levobupivacaine for the realization of the facial block and placebo for intraoperative analgesia</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bilateral facial block after general anesthesia before surgery</intervention_name>
    <description>Bilateral facial block (infraorbital and infratrochlear) after general anesthesia before surgery with intravenous placebo or bilateral block with placebo and intravenous morphine</description>
    <arm_group_label>Control</arm_group_label>
    <arm_group_label>Levobupivacaine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Outpatient rhinoplasty

          -  American Society of Anesthesiologists (ASA) classification I-II

          -  Affiliated to Social Security

          -  Written informed consent

        Exclusion Criteria:

          -  Allergy to levobupivacaine

          -  Incapacity to give consent

          -  Chronic pain
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Hôpital Edouard Herriot</name>
      <address>
        <city>Lyon</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 17, 2014</lastchanged_date>
  <firstreceived_date>June 5, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>facial block</keyword>
  <keyword>levobupivacaine</keyword>
  <keyword>regional anesthesia</keyword>
  <keyword>rhinoplasty</keyword>
  <keyword>outpatient</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Levobupivacaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
